Search research articles
Contact Us
Filters
Showing results (171-180 of 297) with videos related to
Page
of 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer
Marcus Schmidt, Dirk Hasenclever, Mitra Schaeffer, et al.
The Lancet. Oncology
|
June 9, 2015
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
James C-H Yang, Lecia V Sequist, Sarayut Lucien Geater, et al.
Clinical Colorectal Cancer
|
March 13, 2018
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
Marcel Wiesweg, Henning Reis, Tobias Köster, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2025
Early years, advanced disease: The unmet need in young adults with non-small cell lung cancer
Maximilian Webendoerfer, Marcel Wiesweg, Jane Winantea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
Cancers
|
March 28, 2024
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease
Maja Guberina, Christoph Pöttgen, Nika Guberina, et al.
Cancer Science
|
November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
Yung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Respiration; International Review of Thoracic Diseases
|
April 10, 2026
Independent Validation of the LIONS PREY in Patients Undergoing Navigational Bronchoscopy
Erik Büscher, Faustina Funke, Kaid Darwiche, et al.
Page
of 30
Search research articles
Search
Showing results (171-180 of 297) with videos related to
Sort By:
Page
of 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer
Marcus Schmidt, Dirk Hasenclever, Mitra Schaeffer, et al.
The Lancet. Oncology
|
June 9, 2015
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
James C-H Yang, Lecia V Sequist, Sarayut Lucien Geater, et al.
Clinical Colorectal Cancer
|
March 13, 2018
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
Marcel Wiesweg, Henning Reis, Tobias Köster, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2025
Early years, advanced disease: The unmet need in young adults with non-small cell lung cancer
Maximilian Webendoerfer, Marcel Wiesweg, Jane Winantea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
Cancers
|
March 28, 2024
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease
Maja Guberina, Christoph Pöttgen, Nika Guberina, et al.
Cancer Science
|
November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
Yung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Respiration; International Review of Thoracic Diseases
|
April 10, 2026
Independent Validation of the LIONS PREY in Patients Undergoing Navigational Bronchoscopy
Erik Büscher, Faustina Funke, Kaid Darwiche, et al.
Page
of 30